May 12th, 2025 “EURETINA-Brief”© Issue No. 316
Dear EURETINA Members, A very warm welcome to the May 12th, 2025 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
May 12th, 2025
Latest News
May 12th, 2025 “EURETINA-Brief”© Issue No. 316
Dear EURETINA Members, A very warm welcome to the May 12th, 2025 edition of EURETINA’s…
New study on a genome-wide association of central serous chorioretinopathy (CSC), varicose veins and glaucoma identifies a missense variant in PTPRB gene.
Researchers at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, and the Massachusetts…
Natural history of PCARE-associated retinopathy highlights genetics, clinical characteristics and time-to-event curves for development of atrophy.
Clinical researchers at the Sorbonne Université, INSERM, CNRS, Institut de la Vision and the Centre…
Opus Genetics Inc., has announced 12-month summary results for OPGx-LCA5 – an experimental gene therapy treatment of LCA5 retinal disease.
Opus Genetics Inc., (NASDAQ: IRD), based in Raleigh, North Carolina, has announced the one-year summary…